Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: The Oral Rapamune to Inhibit Restenosis (ORBIT) study - Concepedia

Concepedia

Publication | Closed Access

Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: The Oral Rapamune to Inhibit Restenosis (ORBIT) study

49

Citations

0

References

2005

Year

R Waksman, Andrew E. Ajani, A.D. Pichard

ACC Current Journal Review

Percutaneous Coronary InterventionCardiovascular DiseaseMedicineOral RapamuneOral RapamycinPharmacotherapyInhibit RestenosisPharmacologyCardiologyCoronary Artery DiseaseCardiovascular Translational Research

No additional data available for this publication yet. Check back later!